Sponsor or institution

Clinical trials and research at Kirby Institute

• 8Clinical trials
• 2Countries

Newest trials

All recruiting trials (8)

• Moxidectin versus ivermectin mass treatment to control river blindness and other common infections in Angolan villages

  This project will test whether giving moxidectin or ivermectin to whole villages better lowers river blindness and other common infections in people living in selected Angolan communities.

  Recruiting Phase 4 Kirby Institute · Andulo, Bíe Province · NCT07145736

• Point-of-care testing program for Hepatitis C screening

  This study is testing if quick Hepatitis C tests done during a single visit can help more at-risk adults get diagnosed and start treatment faster.

  Recruiting at 6 sites Kirby Institute · Canberra, Australian Capital Territory and 12 other locations · NCT05713136

• Timing of COVID-19 booster vaccinations for immunosuppressed patients

  This study is testing whether giving COVID-19 booster shots right before or six months after starting immunosuppressive therapy helps people with autoimmune and inflammatory conditions stay protected better.

  Recruiting at 5 sites Phase 3 Kirby Institute · Blacktown, New South Wales and 4 other locations · NCT05415267

• Evaluating point-of-care testing for Hepatitis C in Australia

  This study is testing if quick finger-stick tests for Hepatitis C can help people in high-risk areas in Australia get diagnosed and treated more easily.

  Recruiting at 11 sites Kirby Institute · Sydney, New South Wales and 15 other locations · NCT05248555

• National program for point-of-care testing of Hepatitis C in Australia

  This study is testing if quick finger-stick tests for Hepatitis C can help more people at risk get diagnosed and treated in places like drug clinics and prisons.

  Recruiting at 52 sites Kirby Institute · Canberra, Australian Capital Territory and 68 other locations · NCT05042544

• Assessment of people living with chronic hepatitis B in Australia

  This study is looking to understand the care and treatment needs of people living with chronic hepatitis B in Australia by collecting information from those who have visited clinics for their condition.

  Recruiting at 15 sites Kirby Institute · Sydney, New South Wales and 18 other locations · NCT04914611

• Short-term treatment for early liver disease caused by Hepatitis C

  This study is testing a 4-week treatment plan for people with early liver disease caused by Hepatitis C to see if it can safely get rid of the virus.

  Recruiting at 3 sites Phase 4 Kirby Institute · Darlinghurst, New South Wales and 2 other locations · NCT03855917

• Improving hepatitis C treatment in drug treatment clinics

  This study is testing if providing hepatitis C testing and treatment directly at drug treatment clinics can help people who use drugs get better care for their hepatitis C.

  Recruiting at 25 sites Kirby Institute · Canberra, Australian Capital Territory and 31 other locations · NCT03685045

Quick answers

How many clinical trials run by Kirby Institute are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Australia (7 trials), Angola (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →